Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study

Background: Type 2 diabetes is related to an increased risk of dementia. Preclinical studies of dipeptidyl peptidase-IV inhibitors (DPP-4i) for dementia have yielded promising results. Therefore, we investigated the risk of dementia in elderly patients with type 2 diabetes on DPP-4is and sulfonylure...

Full description

Bibliographic Details
Main Authors: Young-Gun Kim, Ja Young Jeon, Hae Jin Kim, Dae Jung Kim, Kwan-Woo Lee, So Young Moon, Seung Jin Han
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:http://www.mdpi.com/2077-0383/8/1/28